GoodRx (GDRX) Competitors $4.50 +0.17 (+3.93%) Closing price 04:00 PM EasternExtended Trading$4.46 -0.04 (-1.00%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GDRX vs. LIF, LYFT, ETSY, AMTM, MARA, QBTS, WPP, HNGE, STNE, and WSCShould you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include Life360 (LIF), Lyft (LYFT), Etsy (ETSY), Amentum (AMTM), Marathon Digital (MARA), D-Wave Quantum (QBTS), WPP (WPP), Hinge Health (HNGE), StoneCo (STNE), and WillScot (WSC). These companies are all part of the "business services" industry. GoodRx vs. Its Competitors Life360 Lyft Etsy Amentum Marathon Digital D-Wave Quantum WPP Hinge Health StoneCo WillScot Life360 (NASDAQ:LIF) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation. Do institutionals & insiders believe in LIF or GDRX? 20.0% of Life360 shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 4.2% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer LIF or GDRX? In the previous week, Life360 had 6 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for Life360 and 5 mentions for GoodRx. GoodRx's average media sentiment score of 0.58 beat Life360's score of 0.30 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GoodRx 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, LIF or GDRX? GoodRx has higher revenue and earnings than Life360. GoodRx is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLife360$427.40M16.51-$4.55M$0.32284.38GoodRx$792.32M1.97$16.39M$0.1045.00 Do analysts prefer LIF or GDRX? Life360 presently has a consensus price target of $86.43, indicating a potential downside of 5.02%. GoodRx has a consensus price target of $5.80, indicating a potential upside of 28.89%. Given GoodRx's higher probable upside, analysts plainly believe GoodRx is more favorable than Life360.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Life360 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00GoodRx 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Is LIF or GDRX more profitable? Life360 has a net margin of 6.45% compared to GoodRx's net margin of 4.33%. GoodRx's return on equity of 8.86% beat Life360's return on equity.Company Net Margins Return on Equity Return on Assets Life3606.45% 7.65% 5.31% GoodRx 4.33%8.86%4.50% Which has more risk & volatility, LIF or GDRX? Life360 has a beta of 3.46, meaning that its stock price is 246% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. SummaryLife360 beats GoodRx on 9 of the 16 factors compared between the two stocks. Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GDRX vs. The Competition Export to ExcelMetricGoodRxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.56B$7.69B$5.74B$9.78BDividend YieldN/A2.74%4.40%4.04%P/E Ratio45.0078.4530.8326.39Price / Sales1.9745.31382.9086.63Price / Cash13.3624.4437.7259.11Price / Book2.4321.9510.106.62Net Income$16.39M$242.04M$3.26B$265.42M7 Day Performance2.97%0.59%3.90%3.58%1 Month Performance-10.00%-0.47%3.73%0.46%1 Year Performance-47.61%9.94%37.68%19.41% GoodRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GDRXGoodRx2.8872 of 5 stars$4.50+3.9%$5.80+28.9%-46.9%$1.56B$792.32M45.00950LIFLife3601.1029 of 5 stars$87.20+2.1%$86.43-0.9%+132.1%$6.76B$427.40M272.51600Insider TradeLYFTLyft4.03 of 5 stars$16.02+1.3%$16.70+4.2%+42.6%$6.51B$5.79B66.752,934Trending NewsETSYEtsy4.0452 of 5 stars$64.96-2.2%$57.20-11.9%+1.9%$6.44B$2.81B52.392,400Trending NewsInsider TradeOptions VolumeAMTMAmentum2.0534 of 5 stars$25.12-0.2%$27.30+8.7%N/A$6.11B$8.39B64.4153,000News CoverageMARAMarathon Digital3.6985 of 5 stars$16.09+2.7%$24.22+50.5%-14.7%$5.96B$656.38M14.509QBTSD-Wave Quantum3.2833 of 5 stars$16.53-2.8%$19.27+16.6%+1,444.0%$5.65B$8.83M-15.743WPPWPP1.8466 of 5 stars$25.41-0.2%N/A-44.5%$5.48B$18.84B4.26108,044HNGEHinge HealthN/A$59.34+0.5%$55.71-6.1%N/A$4.63BN/A0.001,514STNEStoneCo3.3437 of 5 stars$15.44-0.9%$15.07-2.4%+14.4%$4.42B$2.46B-22.0616,793Positive NewsWSCWillScot4.3244 of 5 stars$24.18flat$36.00+48.9%-37.5%$4.40B$2.40B40.304,500Positive News Related Companies and Tools Related Companies Life360 Competitors Lyft Competitors Etsy Competitors Amentum Competitors Marathon Digital Competitors D-Wave Quantum Competitors WPP Competitors Hinge Health Competitors StoneCo Competitors WillScot Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GDRX) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access